» Articles » PMID: 29380180

Targeting Autophagy in Lymphomas: a Double-edged Sword?

Overview
Journal Int J Hematol
Specialty Hematology
Date 2018 Jan 31
PMID 29380180
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Autophagy (also known as macroautophagy) is a lysosomal degradation pathway for the clearance of cellular materials, which manifests as an adaptive response to stress stimuli. Over the past decade, numerous studies have linked autophagy with cancer initiation, progression, and chemoresistance. Autophagy defects in normal cells facilitate tumorigenesis; paradoxically, enhanced autophagy allows prolonged survival in cancer cells upon nutrient shortage, low oxygen, or chemotherapies. However, the mechanism underlying the switch from the cytoprotective role of autophagy to autophagic cell death remains incompletely understood. Here, I review the latest advances in understanding the role of autophagy in lymphomas, current challenges, and future directions.

Citing Articles

Basic Fibroblast Growth Factor Blockade Leads to Distinct Cellular Responses in Melanoma B16 Cells.

Wang Z, Wang M, Lin M, Li J, Song H, Wei P Dokl Biochem Biophys. 2023; 507(1):383-389.

PMID: 36787008 DOI: 10.1134/S1607672922340154.


Autophagy in Hematological Malignancies.

Garcia Ruiz O, Sanchez-Maldonado J, Lopez-Nevot M, Garcia P, Macauda A, Hernandez-Mohedo F Cancers (Basel). 2022; 14(20).

PMID: 36291856 PMC: 9600546. DOI: 10.3390/cancers14205072.


Engineering Nanoplatform for Combined Cancer Therapeutics via Complementary Autophagy Inhibition.

Wang X, Li Y, Lu J, Deng X, Wu Y Int J Mol Sci. 2022; 23(2).

PMID: 35054843 PMC: 8776236. DOI: 10.3390/ijms23020657.


mA mRNA Methylation Regulates LKB1 to Promote Autophagy of Hepatoblastoma Cells through Upregulated Phosphorylation of AMPK.

Li G, Deng L, Huang N, Cui Z, Wu Q, Ma J Genes (Basel). 2021; 12(11).

PMID: 34828353 PMC: 8621998. DOI: 10.3390/genes12111747.


Autophagy-related signaling pathways are involved in cancer (Review).

Chen C, Gao H, Su X Exp Ther Med. 2021; 22(1):710.

PMID: 34007319 PMC: 8120650. DOI: 10.3892/etm.2021.10142.


References
1.
Ni Z, Dai X, Wang B, Ding W, Cheng P, Xu L . Natural Bcl-2 inhibitor (-)- gossypol induces protective autophagy via reactive oxygen species-high mobility group box 1 pathway in Burkitt lymphoma. Leuk Lymphoma. 2013; 54(10):2263-8. DOI: 10.3109/10428194.2013.775437. View

2.
Arsham A, Howell J, Simon M . A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem. 2003; 278(32):29655-60. DOI: 10.1074/jbc.M212770200. View

3.
McCarthy A, Marzec J, Clear A, Petty R, Coutinho R, Matthews J . Dysregulation of autophagy in human follicular lymphoma is independent of overexpression of BCL-2. Oncotarget. 2014; 5(22):11653-68. PMC: 4294376. DOI: 10.18632/oncotarget.2605. View

4.
Cai Q, Medeiros L, Xu X, Young K . MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management. Oncotarget. 2015; 6(36):38591-616. PMC: 4770723. DOI: 10.18632/oncotarget.5774. View

5.
Friedberg J . How I treat double-hit lymphoma. Blood. 2017; 130(5):590-596. DOI: 10.1182/blood-2017-04-737320. View